English

Oragenics, Inc.

EDGAR

OGEN Quarterly report (10-Q) · filed 2026-08-13

124 filing records in this dataset, filed from 2003-08-13 to 2026-08-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2023 Q4 · USD

Exact inputs and evidence

Revenue: 37653 USD Source
Revenue: 37653 USD Source

Operating cash flow

-1.1 million USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -7290880 USD Source
Operating Cash Flow: -6188335 USD Source

Cash and cash equivalents: 3.86 million USD 2026-06-30 Source
Exact value

3864184 USD
Long-term debt including current maturities: Not available
Shares outstanding: 4.51 million shares 2026-06-30 Source
Exact value

4511957 shares

Reported share-count change

448.28% · 3.69 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

822927 shares · 2025-06-30· Source
4511957 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

37.7 thousand USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Revenue: 17024 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 13163 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 7466 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 37653 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 37653 USD · 2023-01-01 – 2023-09-30 Source

Net income

-10 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -3066589 USD · 2025-07-01 – 2025-09-30 Source
Net income: -9800000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -7600000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -2201243 USD · 2026-01-01 – 2026-03-31 Source
Net income: -2528707 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-10.2 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -6400000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -3426460 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -9200000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -6400000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -2200000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -4400000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -2200000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

128 thousand USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Capital expenditure: 87047 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 87047 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 87047 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 124081 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 87047 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 127519 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 124081 USD · 2022-01-01 – 2022-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2023-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2022-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 3 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 767,918

Prior period

−USD 10.57 million

2024-01-01 – 2024-12-31
Current period

−USD 9.8 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-9800000 − -10567918 = 767918 USD

-10567918 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-9800000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Oragenics, Inc. · 2025-12-31 Oragenics, Inc. (edgar:1174940) Year-over-year change in Net income: 767918 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -9800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315226010282/form10-k.htm#1412013 Filing: 000149315226010282 Input fundies:NetIncome: -10567918 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315226010282/form10-k.htm#1381071 Filing: 000149315226010282
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 602,618

Prior period

−USD 8.6 million

2024-01-01 – 2024-12-31
Current period

−USD 9.2 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-9200000 − -8597382 = -602618 USD

-8597382 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-9200000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Oragenics, Inc. · 2025-12-31 Oragenics, Inc. (edgar:1174940) Year-over-year change in Operating cash flow: -602618 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -9200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315226010282/form10-k.htm#1412408 Filing: 000149315226010282 Input fundies:OperatingCashFlow: -8597382 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315226010282/form10-k.htm#1390969 Filing: 000149315226010282
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 37,653 100% of revenue
Operating costs Derived USD 20.94 million 55,620% of revenue
Operating income −USD 20.9 million −55,520% of revenue
Tax, interest and other Derived −USD 249,166 −662% of revenue
Net income −USD 20.66 million −54,858% of revenue

Cash

Operating cash flow −USD 7.29 million −19,363% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2021 Operating loss: operating costs were 18,230% of revenue.
2022 Operating loss: operating costs were 11,065% of revenue.
2023 Operating loss: operating costs were 55,620% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	0	8542505 Derived	-8542505	-1529201 Derived	-7013304	-7102264 Derived	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -8542505 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -7013304 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -7075085 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 27179 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	0	6718318 Derived	-6718318	13207 Derived	-6731525	Unavailable	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6718318 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -6731525 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -6363853 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	86987	15858005 Derived	-15771018	-59404 Derived	-15711614	-13514088 Derived	Source 2021-01-01 – 2021-12-31: 86987 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -15771018 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -15711614 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -13470212 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 43876 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	131521	14552289 Derived	-14420768	-132379 Derived	-14288389	-15356002 Derived	Source 2022-01-01 – 2022-12-31: 131521 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -14420768 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -14288389 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -15228483 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 127519 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	37653	20942556 Derived	-20904903	-249166 Derived	-20655737	Unavailable	Source 2023-01-01 – 2023-12-31: 37653 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -20904903 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -20655737 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -7290880 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 37.7K 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	0	Revenue: 0 Open source
20162016-12-31	Revenue	0	Revenue: 0 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20212021-12-31	Revenue	86987	Revenue: 86987 Open source
20222022-12-31	Revenue	131521	Revenue: 131521 Open source
20232023-12-31	Revenue	37653	Revenue: 37653 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-71.4% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20212021-12-31	Year over year	No prior comparable period	Revenue: 86987 Open source
20222022-12-31	Year over year	51.2%	Revenue: 131521 Open source Revenue: 86987 Open source
20232023-12-31	Year over year	-71.4%	Revenue: 37653 Open source Revenue: 131521 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -55,519.9% 2023

Net margin -54,858.1% 2023

Free cash flow margin -11,675.7% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	Not reported	Operating Income: -11780864 Open source Revenue: 0 Open source
20162016-12-31	Operating margin	Not reported	Operating Income: -8542505 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -6718318 Open source Revenue: 0 Open source
20212021-12-31	Operating margin	-18,130.3%	Operating Income: -15771018 Open source Revenue: 86987 Open source
20222022-12-31	Operating margin	-10,964.6%	Operating Income: -14420768 Open source Revenue: 131521 Open source
20232023-12-31	Operating margin	-55,519.9%	Operating Income: -20904903 Open source Revenue: 37653 Open source
20152015-12-31	Net margin	Not reported	Net Income: -11711333 Open source Revenue: 0 Open source
20162016-12-31	Net margin	Not reported	Net Income: -7013304 Open source Revenue: 0 Open source
20172017-12-31	Net margin	Not reported	Net Income: -6731525 Open source Revenue: 0 Open source
20212021-12-31	Net margin	-18,062%	Net Income: -15711614 Open source Revenue: 86987 Open source
20222022-12-31	Net margin	-10,864%	Net Income: -14288389 Open source Revenue: 131521 Open source
20232023-12-31	Net margin	-54,858.1%	Net Income: -20655737 Open source Revenue: 37653 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -7075085 Open source Capital Expenditure: 27179 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6363853 Open source
20212021-12-31	Free cash flow margin	-15,535.8%	Revenue: 86987 Open source Operating Cash Flow: -13470212 Open source Capital Expenditure: 43876 Open source
20222022-12-31	Free cash flow margin	-11,675.7%	Revenue: 131521 Open source Operating Cash Flow: -15228483 Open source Capital Expenditure: 127519 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 37653 Open source Operating Cash Flow: -7290880 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -7.3M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	Not reported	No source recorded
20162016-12-31	Operating cash flow	-7075085	Operating Cash Flow: -7075085 Open source
20172017-12-31	Operating cash flow	-6363853	Operating Cash Flow: -6363853 Open source
20212021-12-31	Operating cash flow	-13470212	Operating Cash Flow: -13470212 Open source
20222022-12-31	Operating cash flow	-15228483	Operating Cash Flow: -15228483 Open source
20232023-12-31	Operating cash flow	-7290880	Operating Cash Flow: -7290880 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -15.4M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	Unavailable	No source recorded
20162016-12-31	Free cash flow	-7102264	Operating Cash Flow: -7075085 Open source Capital Expenditure: 27179 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -6363853 Open source
20212021-12-31	Free cash flow	-13514088	Operating Cash Flow: -13470212 Open source Capital Expenditure: 43876 Open source
20222022-12-31	Free cash flow	-15356002	Operating Cash Flow: -15228483 Open source Capital Expenditure: 127519 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7290880 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

36.2% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	Total Assets: 5778379 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 4309166 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 7214831 Open source
2021-12-31	Liabilities / assets	Not reported	Total Assets: 28230979 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 14758025 Open source
20232023-12-31	Liabilities / assets	36.2%	Total Liabilities: 1798181 Open source Total Assets: 4966335 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.15× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	5.38×	Current Assets: 5637728 Open source Current Liabilities: 1047354 Open source
20162016-12-31	Current assets / current liabilities	3.14×	Current Assets: 4221704 Open source Current Liabilities: 1343443 Open source
20172017-12-31	Current assets / current liabilities	8.01×	Current Assets: 7193172 Open source Current Liabilities: 898522 Open source
20212021-12-31	Current assets / current liabilities	19.17×	Current Assets: 27707389 Open source Current Liabilities: 1445260 Open source
20222022-12-31	Current assets / current liabilities	8.95×	Current Assets: 14289523 Open source Current Liabilities: 1596284 Open source
20232023-12-31	Current assets / current liabilities	2.15×	Current Assets: 3865774 Open source Current Liabilities: 1798181 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 7.01 million Exact value Exact value: -7013304 USD 2016-01-01 – 2016-12-31: -7013304 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2016-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -7013304 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7013304 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000119312518048564/ogen-20171231.xml#521476 Filing: 000119312518048564 The citation records this snapshot. The page link may show a newer release later.	−USD 7.08 million Exact value Exact value: -7075085 USD 2016-01-01 – 2016-12-31: -7075085 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2016-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -7075085 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7075085 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000119312518048564/ogen-20171231.xml#521210 Filing: 000119312518048564 The citation records this snapshot. The page link may show a newer release later.	USD 27,179 Exact value Exact value: 27179 USD 2016-01-01 – 2016-12-31: 27179 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oragenics, Inc. · 2016-12-31 Oragenics, Inc. (edgar:1174940) Capital Expenditure: 27179 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27179 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000119312518048564/ogen-20171231.xml#522585 Filing: 000119312518048564 The citation records this snapshot. The page link may show a newer release later.	−USD 7.1 million Calculation and evidence -7075085 − 27179 USD Exact free cash flow: -7102264 USD 2016-01-01 – 2016-12-31: -7075085 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 27179 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oragenics, Inc. · 2016-12-31 Oragenics, Inc. (edgar:1174940) Free cash flow: -7102264 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7075085 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000119312518048564/ogen-20171231.xml#521210 Filing: 000119312518048564 Input fundies:CapitalExpenditure: 27179 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000119312518048564/ogen-20171231.xml#522585 Filing: 000119312518048564 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 6.73 million Exact value Exact value: -6731525 USD 2017-01-01 – 2017-12-31: -6731525 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2017-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -6731525 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6731525 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000156459019010173/ogen-20181231.xml#147877 Filing: 000156459019010173 The citation records this snapshot. The page link may show a newer release later.	−USD 6.36 million Exact value Exact value: -6363853 USD 2017-01-01 – 2017-12-31: -6363853 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2017-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -6363853 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6363853 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000156459019010173/ogen-20181231.xml#176100 Filing: 000156459019010173 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 9.91 million Exact value Exact value: -9914141 USD 2018-01-01 – 2018-12-31: -9914141 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2018-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -9914141 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9914141 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315220003343/ogen-20191231.xml#150635 Filing: 000149315220003343 The citation records this snapshot. The page link may show a newer release later.	−USD 9.08 million Exact value Exact value: -9079817 USD 2018-01-01 – 2018-12-31: -9079817 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2018-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -9079817 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9079817 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315220003343/ogen-20191231.xml#191577 Filing: 000149315220003343 The citation records this snapshot. The page link may show a newer release later.	USD 124,727 Exact value Exact value: 124727 USD 2018-01-01 – 2018-12-31: 124727 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oragenics, Inc. · 2018-12-31 Oragenics, Inc. (edgar:1174940) Capital Expenditure: 124727 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 124727 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315220003343/ogen-20191231.xml#191948 Filing: 000149315220003343 The citation records this snapshot. The page link may show a newer release later.	−USD 9.2 million Calculation and evidence -9079817 − 124727 USD Exact free cash flow: -9204544 USD 2018-01-01 – 2018-12-31: -9079817 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 124727 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oragenics, Inc. · 2018-12-31 Oragenics, Inc. (edgar:1174940) Free cash flow: -9204544 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9079817 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315220003343/ogen-20191231.xml#191577 Filing: 000149315220003343 Input fundies:CapitalExpenditure: 124727 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315220003343/ogen-20191231.xml#191948 Filing: 000149315220003343 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 15.57 million Exact value Exact value: -15566003 USD 2019-01-01 – 2019-12-31: -15566003 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2019-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -15566003 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15566003 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315221005122/ogen-20201231.xml#116919 Filing: 000149315221005122 The citation records this snapshot. The page link may show a newer release later.	−USD 13.01 million Exact value Exact value: -13012843 USD 2019-01-01 – 2019-12-31: -13012843 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2019-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -13012843 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13012843 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315221005122/ogen-20201231.xml#171708 Filing: 000149315221005122 The citation records this snapshot. The page link may show a newer release later.	USD 25,214 Exact value Exact value: 25214 USD 2019-01-01 – 2019-12-31: 25214 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oragenics, Inc. · 2019-12-31 Oragenics, Inc. (edgar:1174940) Capital Expenditure: 25214 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25214 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315221005122/ogen-20201231.xml#171340 Filing: 000149315221005122 The citation records this snapshot. The page link may show a newer release later.	−USD 13.04 million Calculation and evidence -13012843 − 25214 USD Exact free cash flow: -13038057 USD 2019-01-01 – 2019-12-31: -13012843 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 25214 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oragenics, Inc. · 2019-12-31 Oragenics, Inc. (edgar:1174940) Free cash flow: -13038057 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13012843 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315221005122/ogen-20201231.xml#171708 Filing: 000149315221005122 Input fundies:CapitalExpenditure: 25214 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315221005122/ogen-20201231.xml#171340 Filing: 000149315221005122 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 26.43 million Exact value Exact value: -26430699 USD 2020-01-01 – 2020-12-31: -26430699 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2020-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -26430699 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26430699 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315222020698/form10-ka.htm#2110052 Filing: 000149315222020698 The citation records this snapshot. The page link may show a newer release later.	−USD 16.95 million Exact value Exact value: -16952864 USD 2020-01-01 – 2020-12-31: -16952864 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2020-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -16952864 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16952864 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315222020698/form10-ka.htm#2118508 Filing: 000149315222020698 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 15.71 million Exact value Exact value: -15711614 USD 2021-01-01 – 2021-12-31: -15711614 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2021-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -15711614 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15711614 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315223012617/form10-k.htm#2050133 Filing: 000149315223012617 The citation records this snapshot. The page link may show a newer release later.	−USD 13.47 million Exact value Exact value: -13470212 USD 2021-01-01 – 2021-12-31: -13470212 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2021-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -13470212 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13470212 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315223012617/form10-k.htm#2064218 Filing: 000149315223012617 The citation records this snapshot. The page link may show a newer release later.	USD 43,876 Exact value Exact value: 43876 USD 2021-01-01 – 2021-12-31: 43876 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oragenics, Inc. · 2021-12-31 Oragenics, Inc. (edgar:1174940) Capital Expenditure: 43876 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 43876 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315223012617/form10-k.htm#2068884 Filing: 000149315223012617 The citation records this snapshot. The page link may show a newer release later.	−USD 13.51 million Calculation and evidence -13470212 − 43876 USD Exact free cash flow: -13514088 USD 2021-01-01 – 2021-12-31: -13470212 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 43876 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oragenics, Inc. · 2021-12-31 Oragenics, Inc. (edgar:1174940) Free cash flow: -13514088 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13470212 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315223012617/form10-k.htm#2064218 Filing: 000149315223012617 Input fundies:CapitalExpenditure: 43876 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315223012617/form10-k.htm#2068884 Filing: 000149315223012617 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 14.29 million Exact value Exact value: -14288389 USD 2022-01-01 – 2022-12-31: -14288389 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2022-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -14288389 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14288389 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315224011979/form10-k.htm#1808937 Filing: 000149315224011979 The citation records this snapshot. The page link may show a newer release later.	−USD 15.23 million Exact value Exact value: -15228483 USD 2022-01-01 – 2022-12-31: -15228483 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2022-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -15228483 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15228483 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315224011979/form10-k.htm#1819810 Filing: 000149315224011979 The citation records this snapshot. The page link may show a newer release later.	USD 127,519 Exact value Exact value: 127519 USD 2022-01-01 – 2022-12-31: 127519 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oragenics, Inc. · 2022-12-31 Oragenics, Inc. (edgar:1174940) Capital Expenditure: 127519 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 127519 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315224011979/form10-k.htm#1822926 Filing: 000149315224011979 The citation records this snapshot. The page link may show a newer release later.	−USD 15.36 million Calculation and evidence -15228483 − 127519 USD Exact free cash flow: -15356002 USD 2022-01-01 – 2022-12-31: -15228483 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 127519 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oragenics, Inc. · 2022-12-31 Oragenics, Inc. (edgar:1174940) Free cash flow: -15356002 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15228483 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315224011979/form10-k.htm#1819810 Filing: 000149315224011979 Input fundies:CapitalExpenditure: 127519 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315224011979/form10-k.htm#1822926 Filing: 000149315224011979 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 20.66 million Exact value Exact value: -20655737 USD 2023-01-01 – 2023-12-31: -20655737 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2023-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -20655737 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20655737 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315225010389/form10-k.htm#1656168 Filing: 000149315225010389 The citation records this snapshot. The page link may show a newer release later.	−USD 7.29 million Exact value Exact value: -7290880 USD 2023-01-01 – 2023-12-31: -7290880 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2023-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -7290880 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7290880 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315225010389/form10-k.htm#1673458 Filing: 000149315225010389 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−USD 10.57 million Exact value Exact value: -10567918 USD 2024-01-01 – 2024-12-31: -10567918 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2024-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -10567918 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10567918 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315226010282/form10-k.htm#1381071 Filing: 000149315226010282 The citation records this snapshot. The page link may show a newer release later.	−USD 8.6 million Exact value Exact value: -8597382 USD 2024-01-01 – 2024-12-31: -8597382 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2024-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -8597382 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8597382 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315226010282/form10-k.htm#1390969 Filing: 000149315226010282 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	−USD 9.8 million Exact value Exact value: -9800000 USD 2025-01-01 – 2025-12-31: -9800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oragenics, Inc. · 2025-12-31 Oragenics, Inc. (edgar:1174940) Net Income: -9800000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315226010282/form10-k.htm#1412013 Filing: 000149315226010282 The citation records this snapshot. The page link may show a newer release later.	−USD 9.2 million Exact value Exact value: -9200000 USD 2025-01-01 – 2025-12-31: -9200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oragenics, Inc. · 2025-12-31 Oragenics, Inc. (edgar:1174940) Operating Cash Flow: -9200000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:21:22Z Snapshot: 7aa45046dbc0871971eeeb597b1ffa52f46f46c89139e5fe75417f174a321606 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174940/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174940/000149315226010282/form10-k.htm#1412408 Filing: 000149315226010282 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

124 filings · 3,672 latest values · 3,712 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001174940, 1174940, OGEN, ORNI, edgar:1174940

Also known as ORAGENICS INC, ORAGENICS, INC., ORAGENICS, INC., Oragenics, Inc.

Oragenics, Inc.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation